VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+10.35%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$113M
AUM Growth
+$113M
(-1.9%)
Cap. Flow
-$8.35M
Cap. Flow
% of AUM
-7.38%
Top 10 Holdings %
Top 10 Hldgs %
14.17%
Holding
280
New
34
Increased
62
Reduced
100
Closed
19
Top Buys
| 1 |
Fidelity MSCI Financials Index ETF
FNCL
|
$1.41M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$1.15M |
| 3 |
Verastem
VSTM
|
$985K |
| 4 |
Arrowhead Research
ARWR
|
$933K |
| 5 |
Cartesian Therapeutics
RNAC
|
$884K |
Top Sells
Sector Composition
| 1 | Healthcare | 77.9% |
| 2 | Financials | 0.8% |
| 3 | Technology | 0.58% |
| 4 | Consumer Discretionary | 0.4% |
| 5 | Energy | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
51
DELISTED
Sage Therapeutics
SAGE
| $771K | 0.68% | 4,923 +152 | +3% | +$23.8K |
|
|
TSRO
52
DELISTED
TESARO, Inc.
TSRO
| $770K | 0.68% | 17,317 +5,926 | +52% | +$263K |
|
|
ACHN
53
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $768K | 0.68% | 271,426 +9,142 | +3% | +$25.9K |
|
|
SGYP
54
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $768K | 0.68% | +441,461 | New | +$768K |
|
55
BioMarin Pharmaceuticals
BMRN
$11.2B
| $764K | 0.68% | 8,114 -2,197 | -21% | -$207K |
|
56
Esperion Therapeutics
ESPR
$448M
| $764K | 0.68% | 19,484 +6,541 | +51% | +$256K |
|
57
Karyopharm Therapeutics
KPTI
$61.7M
| $764K | 0.68% | 44,986 -36,339 | -45% | -$617K |
|
|
ECYT
58
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $764K | 0.68% | +55,345 | New | +$764K |
|
|
LJPC
59
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $764K | 0.68% | 26,180 -4,993 | -16% | -$146K |
|
60
Adverum Biotechnologies
ADVM
$64.6M
| $763K | 0.67% | +143,951 | New | +$763K |
|
61
Enanta Pharmaceuticals
ENTA
$180M
| $762K | 0.67% | 6,577 -9,036 | -58% | -$1.05M |
|
62
Rhythm Pharmaceuticals
RYTM
$6.85B
| $762K | 0.67% | +24,374 | New | +$762K |
|
63
Gilead Sciences
GILD
$140B
| $761K | 0.67% | 10,744 -1,802 | -14% | -$128K |
|
64
Vanda Pharmaceuticals
VNDA
$279M
| $760K | 0.67% | 39,895 -24,145 | -38% | -$460K |
|
|
ARRY
65
DELISTED
Array Biopharma Inc
ARRY
| $757K | 0.67% | 45,087 -23,676 | -34% | -$398K |
|
66
Madrigal Pharmaceuticals
MDGL
$9.76B
| $755K | 0.67% | 2,699 -6,930 | -72% | -$1.94M |
|
|
IMGN
67
DELISTED
Immunogen Inc
IMGN
| $753K | 0.67% | 77,365 -35,182 | -31% | -$342K |
|
|
ICPT
68
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $753K | 0.67% | 8,970 -5,711 | -39% | -$479K |
|
|
PRTK
69
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $752K | 0.66% | 73,770 +31,037 | +73% | +$316K |
|
70
Ironwood Pharmaceuticals
IRWD
$214M
| $751K | 0.66% | 39,291 -19,723 | -33% | -$377K |
|
71
Fate Therapeutics
FATE
$120M
| $749K | 0.66% | +66,073 | New | +$749K |
|
72
Alnylam Pharmaceuticals
ALNY
$58.5B
| $747K | 0.66% | 7,581 +1,529 | +25% | +$151K |
|
73
MediciNova
MNOV
$64.3M
| $746K | 0.66% | +93,768 | New | +$746K |
|
74
MacroGenics
MGNX
$112M
| $745K | 0.66% | 36,070 -3,184 | -8% | -$65.8K |
|
75
Rocket Pharmaceuticals
RCKT
$354M
| $741K | 0.66% | +37,750 | New | +$741K |
|